Thymic Epithelial Tumor
18
7
8
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (18)
PT-112 in Subjects With Thymoma and Thymic Carcinoma
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)
Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
Molecular Analysis and Treatment Options of Thymic Malignancies
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
RATT Vs. VATT for Early-stage TETs
Establishing Prospective Mediastinal Tumor Database of PUMCH
Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
French National Observatory of Patients With Thymic Epithelial Tumor
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence
neoadjuvant_thymic Epithelial Tumor
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging